share_log

Heart Test Laboratories | CORRESP: CORRESP

Heart Test Laboratories | CORRESP: CORRESP

Heart Test Laboratories | CORRESP:信函
美股sec公告 ·  03/12 12:58
Moomoo AI 已提取核心信息
Heart Test Laboratories, Inc., a medical technology company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1 to 4:00 P.M. Eastern Time on March 13, 2024. The request, filed on March 12, 2024, aims for the registration to be effective as soon as possible or at a time thereafter as determined by the company's counsel. This step is part of the process for Heart Test Laboratories to become a publicly-traded company, allowing it to issue stocks to the public. The company has indicated that its counsel, Foley Shechter Ablovatskiy LLP, should be notified by phone upon the registration statement's effectiveness.
Heart Test Laboratories, Inc., a medical technology company, has formally requested the United States Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-1 to 4:00 P.M. Eastern Time on March 13, 2024. The request, filed on March 12, 2024, aims for the registration to be effective as soon as possible or at a time thereafter as determined by the company's counsel. This step is part of the process for Heart Test Laboratories to become a publicly-traded company, allowing it to issue stocks to the public. The company has indicated that its counsel, Foley Shechter Ablovatskiy LLP, should be notified by phone upon the registration statement's effectiveness.
医疗技术公司Heart Test Laboratories, Inc. 已正式要求美国证券交易委员会(SEC)将其S-1表格注册声明的生效日期加快至美国东部时间2024年3月13日下午4点。该请求于2024年3月12日提出,旨在使注册尽快生效,或在公司法律顾问确定的某个时间生效。这一步是心脏测试实验室成为上市公司的过程的一部分,允许其向公众发行股票。该公司表示,注册声明生效后,应通过电话通知其律师Foley Shechter Ablovatskiy LLP。
医疗技术公司Heart Test Laboratories, Inc. 已正式要求美国证券交易委员会(SEC)将其S-1表格注册声明的生效日期加快至美国东部时间2024年3月13日下午4点。该请求于2024年3月12日提出,旨在使注册尽快生效,或在公司法律顾问确定的某个时间生效。这一步是心脏测试实验室成为上市公司的过程的一部分,允许其向公众发行股票。该公司表示,注册声明生效后,应通过电话通知其律师Foley Shechter Ablovatskiy LLP。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息